Company: GCL
Filing Date: 2025-08-27
Form Type: DRS
Source: 0001213900-25-080905
Chunk: 3

Company: GCL Global Holdings Ltd
Filing Date: 2025-08-27
Form: DRS
Chunk 3
---
 securities covered by this prospectus. The Selling Shareholders may
offer and sell the securities covered by this prospectus through ordinary brokerage transactions, directly to market makers of our securities
or through any other means described in the section entitled “Plan of Distribution” herein. In connection with any
sales of the securities offered hereunder, the Selling Shareholders, any underwriters, agents, brokers or dealers participating in such
sales may be deemed to be “underwriters” within the meaning of the Securities Act of 1933, as amended (the “Securities
Act”).

We will pay certain fees
in connection with the registration of the securities and will not receive proceeds from the sale of the securities by the Selling Shareholders,
as described in more detail in the section titled “Use of Proceeds” appearing elsewhere in this prospectus.

On February 14, 2025, our
Ordinary Shares and Warrants commenced trading on The Nasdaq Stock Market LLC (“Nasdaq”) under the symbols “GCL”
and “GCLWW,” respectively. As of August 25, 2025, the closing price of our Ordinary Shares and Warrants was $3.53 and $0.09,
respectively.

The total number of Ordinary
Shares issued and outstanding as of the date of this prospectus are 126,318,225 Ordinary Shares and 121,989,831 Ordinary Shares, respectively.
Each Ordinary Share is entitled to one vote. As of the date of this prospectus, Jacky Choo See Wee, our chairman of the board of directors,
is able to exercise voting rights with respect to over 50% of the voting power of our issued and outstanding shares through his beneficial
ownership of 80,581,793 Ordinary Shares. We are a “controlled company” as defined under the Corporate Governance Rules of
Nasdaq. For so long as we remain a controlled company under this definition, we are permitted to elect to rely, and currently rely, on
certain exemptions from corporate governance rules, including the exemption from the rule that a majority of our board of directors must
be independent directors. For details, see “Risk Factors - We are a “controlled company” under the Corporate Governance Rules of Nasdaq and can rely on exemptions from certain corporate governance requirements that could adversely affect our public shareholders.”
beginning on page 27.

We may amend or supplement
this prospectus from time to time by filing amendments or supplements as required. You should read this entire prospectus